Zafar Hijazi s remand extended for 3 days in record-tampering case

ISLAMABAD – A court on Wednesday extended the physical remand of former chief of Securities and Exchange Commission of Pakistan (SECP) Zafar Hijaz in a case regarding tampering with the record.

The Federal Investigation Agency (FIA) presented the accused before the court following the expiry of four-day physical remand and asked the judge to extend the remand.

During the hearing, the judge asked about interrogation made during last four days from Hijazi, on which the FIA official informed the court that the accused was in the hospital for two days due to health issues.

The court approved the remand and directed the FIA to present him again on July 29.

Earlier, he was remanded into the custody of the FIA on July 22 for four days.

On July 21, the Federal Investigation Agency took Hijazi into custody after the court cancelled his bail in record tampering case.

A special judge central ordered to cancel the bail of the SECP chief, who had been granted bail for five days on July 17 by the same court.

Earlier, on July 13, Zafar Hijazi was granted a transit bail till Monday (July 17) by the IHC bench, headed by Justice Mohsin Akhtar Kayani.

Hijazi has been under the radar ever since the six-member Joint Investigation Team disclosed before the supreme court that SECP was tampering with the record pertaining to Chaudhry Sugar Mills of ruling Sharif family.

On July 10, when the JIT submitted its final report, the supreme court ordered registration of criminal case against Zafar Hijazi.

Acting upon the apex court’s orders, the Federal Investigation Agency (FIA) filed the case with the Special Investigation Unit.

The criminal case was registered against the official under sections 466 and 471 of the Pakistan Penal Code.

Section 466 lists a seven-year imprisonment and fine for those who forge a legal document, while section 471 punishes in the same manner for using as genuine a forged document, Geo News reported.

More from this category

Advertisment

Advertisment

Follow us on Facebook

Search